Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric A Severson

Showing results (21-30 of 48) with videos related to

Pageof 5
Sort By:
Cancer Medicine|December 14, 2020
Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast CancerAbirami Sivapiragasam, Prashanth Ashok Kumar, Ethan S Sokol, et al.
Frontiers in Genetics|May 19, 2025
RNA hybrid-capture next-generation sequencing has high sensitivity in identifying known and less characterized oncogenic and likely oncogenic <i>NTRK</i> fusions in a real-world standard-of-care settingZachary D Wallen, Marni Tierno, Erica Schnettler, et al.
The Journal of Experimental Medicine|November 28, 2007
JAM-A regulates permeability and inflammation in the intestine in vivoMike G Laukoetter, Porfirio Nava, Winston Y Lee, et al.
Scientific Reports|October 23, 2025
Correction: RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancerKyle C Strickland, Zachary D Wallen, Heidi C Ko, et al.
Gynecologic Oncology Reports|October 7, 2020
Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian originDouglas I Lin, Nikunj Shah, Julie Y Tse, et al.
Scientific Reports|August 12, 2025
RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancerKyle C Strickland, Zachary D Wallen, Heidi C Ko, et al.
Gynecologic Oncology|December 4, 2024
Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancersRebecca A Previs, Kyle C Strickland, Zachary Wallen, et al.
The Oncologist|September 6, 2018
Genomic Landscape of Adult and Pediatric <i>BCR-ABL1</i>-Like B-Lymphoblastic Leukemia Using Parallel DNA and RNA SequencingEric A Severson, Jo-Anne Vergilio, Laurie M Gay, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2019
SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation associationDouglas I Lin, Justin M Allen, Jonathan L Hecht, et al.
Gynecologic Oncology|March 12, 2020
Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A lossDouglas I Lin, Amanda Hemmerich, Claire Edgerly, et al.
Pageof 5

Showing results (21-30 of 48) with videos related to

Sort By:
Pageof 5
Cancer Medicine|December 14, 2020
Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast CancerAbirami Sivapiragasam, Prashanth Ashok Kumar, Ethan S Sokol, et al.
Frontiers in Genetics|May 19, 2025
RNA hybrid-capture next-generation sequencing has high sensitivity in identifying known and less characterized oncogenic and likely oncogenic <i>NTRK</i> fusions in a real-world standard-of-care settingZachary D Wallen, Marni Tierno, Erica Schnettler, et al.
The Journal of Experimental Medicine|November 28, 2007
JAM-A regulates permeability and inflammation in the intestine in vivoMike G Laukoetter, Porfirio Nava, Winston Y Lee, et al.
Scientific Reports|October 23, 2025
Correction: RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancerKyle C Strickland, Zachary D Wallen, Heidi C Ko, et al.
Gynecologic Oncology Reports|October 7, 2020
Molecular profiling of mesonephric and mesonephric-like carcinomas of cervical, endometrial and ovarian originDouglas I Lin, Nikunj Shah, Julie Y Tse, et al.
Scientific Reports|August 12, 2025
RB1 expression and HR proficiency define a poor prognosis subtype of high grade serous ovarian cancerKyle C Strickland, Zachary D Wallen, Heidi C Ko, et al.
Gynecologic Oncology|December 4, 2024
Analysis of real world FRα testing in ovarian, fallopian tube, and primary peritoneal cancersRebecca A Previs, Kyle C Strickland, Zachary Wallen, et al.
The Oncologist|September 6, 2018
Genomic Landscape of Adult and Pediatric <i>BCR-ABL1</i>-Like B-Lymphoblastic Leukemia Using Parallel DNA and RNA SequencingEric A Severson, Jo-Anne Vergilio, Laurie M Gay, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|June 14, 2019
SMARCA4 inactivation defines a subset of undifferentiated uterine sarcomas with rhabdoid and small cell features and germline mutation associationDouglas I Lin, Justin M Allen, Jonathan L Hecht, et al.
Gynecologic Oncology|March 12, 2020
Genomic profiling of BCOR-rearranged uterine sarcomas reveals novel gene fusion partners, frequent CDK4 amplification and CDKN2A lossDouglas I Lin, Amanda Hemmerich, Claire Edgerly, et al.
Pageof 5